Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-23T06:04:06.452Z Has data issue: false hasContentIssue false

Oxytocinasemi a in Multiple Pregnancy

Published online by Cambridge University Press:  01 August 2014

R. Klimek*
Affiliation:
Department of Obstetrics and Gynecology, Academy of Medicine, Cracow, Poland
C. Bryniak
Affiliation:
Department of Obstetrics and Gynecology, Academy of Medicine, Cracow, Poland
W. Kallista-Milewicz
Affiliation:
Department of Obstetrics and Gynecology, Academy of Medicine, Cracow, Poland
S. Milewicz
Affiliation:
Department of Obstetrics and Gynecology, Academy of Medicine, Cracow, Poland
A. Paradysz
Affiliation:
Department of Obstetrics and Gynecology, Academy of Medicine, Cracow, Poland
*
Deportment of Obstetrics and Gynecology, Academy of Medicine, ul. Kopernika 23, 31-501 Cracow, Poland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The determination of oxytocinasemia is the method of choice in monitoring multiple pregnancy. An increase in the level of the enzyme indicates a normal development of the pregnancy.

Although, as a rule, the oxytocinasemia level is higher in multiple than in single pregnancy, there are cases with a level pointing to intrauterine fetal danger, if, in a gestation beyond the seventh lunar month, it is lower than 4 μmol∣l∣min.

The birth of a newborn with a body weight below 2500 g, when the oxytocinasemia level exceeds 12 I.U., indicates that a multiple pregnancy is involved.

Type
1. Multiple Pregnancy as a High-Risk Pregnancy
Copyright
Copyright © The International Society for Twin Studies 1972